St. Petersburg, Russia
Novartis International AG will begin construction in 2011 on a pharmaceutical manufacturing plant in St. Peterburg, Russia. The project is part of a five-year, $500 million investment by Novartis in local infrastructure, healthcare initiatives, and partnerships with academia and industry.
